A new frontier in the battle against infant acute lymphoblastic leukemia.
作者信息
Tomizawa Daisuke
机构信息
Division of Leukemia and Lymphoma, Children's Cancer Center, National Center for Child Health and Development, Tokyo.
出版信息
Haematologica. 2024 Dec 1;109(12):3838-3840. doi: 10.3324/haematol.2024.285975.
Abstract
摘要
相似文献
1
A new frontier in the battle against infant acute lymphoblastic leukemia.
Haematologica. 2024 Dec 1;109(12):3838-3840. doi: 10.3324/haematol.2024.285975.
2
Frequencies and prognostic impact of RAS mutations in MLL-rearranged acute lymphoblastic leukemia in infants.
Haematologica. 2013 Jun;98(6):937-44. doi: 10.3324/haematol.2012.067983. Epub 2013 Feb 12.
3
Unraveling the cellular origin and clinical prognostic markers of infant B-cell acute lymphoblastic leukemia using genome-wide analysis.
Haematologica. 2019 Jun;104(6):1176-1188. doi: 10.3324/haematol.2018.206375. Epub 2019 Jan 24.
4
Prognosis of children with mixed phenotype acute leukemia treated on the basis of consistent immunophenotypic criteria.
Haematologica. 2010 Jun;95(6):928-35. doi: 10.3324/haematol.2009.014506. Epub 2010 Feb 9.
5
Backtracking childhood leukaemia to birth: A battle of addition.
Br J Haematol. 2024 Nov;205(5):1670-1671. doi: 10.1111/bjh.19747. Epub 2024 Sep 5.
6
Prognostic factors and outcomes of infant acute lymphoblastic leukemia (ALL), hypodiploid ALL, and mixed-phenotype acute leukemia (MPAL) in Canada: a report from CYP-C.
Leuk Lymphoma. 2022 Dec;63(13):3208-3216. doi: 10.1080/10428194.2022.2118536. Epub 2022 Sep 6.
7
Altered brain function in new onset childhood acute lymphoblastic leukemia before chemotherapy: A resting-state fMRI study.
Brain Dev. 2017 Oct;39(9):743-750. doi: 10.1016/j.braindev.2017.04.014. Epub 2017 May 22.
8
Quantitation of Human herpes virus 6 genome in children with acute lymphoblastic leukemia.
J Med Virol. 2008 Apr;80(4):689-93. doi: 10.1002/jmv.21118.
9
ICU Admission in Children With Acute Lymphoblastic Leukemia in Sweden: Prevalence, Outcome, and Risk Factors.
Pediatr Crit Care Med. 2021 Dec 1;22(12):1050-1060. doi: 10.1097/PCC.0000000000002787.
10
Age- and sex-specific incidence of childhood leukemia by immunophenotype in the Nordic countries.
J Natl Cancer Inst. 2003 Oct 15;95(20):1539-44. doi: 10.1093/jnci/djg064.
本文引用的文献
1
Azacitidine as epigenetic priming for chemotherapy is safe and well-tolerated in infants with newly diagnosed -rearranged acute lymphoblastic leukemia: Children's Oncology Group trial AALL15P1.
Haematologica. 2024 Dec 1;109(12):3918-3927. doi: 10.3324/haematol.2024.285158.
2
Blinatumomab Added to Chemotherapy in Infant Lymphoblastic Leukemia.
N Engl J Med. 2023 Apr 27;388(17):1572-1581. doi: 10.1056/NEJMoa2214171.
3
FLT3 inhibitor lestaurtinib plus chemotherapy for newly diagnosed KMT2A-rearranged infant acute lymphoblastic leukemia: Children's Oncology Group trial AALL0631.
Leukemia. 2021 May;35(5):1279-1290. doi: 10.1038/s41375-021-01177-6. Epub 2021 Feb 23.
4
A risk-stratified therapy for infants with acute lymphoblastic leukemia: a report from the JPLSG MLL-10 trial.
Blood. 2020 Oct 15;136(16):1813-1823. doi: 10.1182/blood.2019004741.
5
Outcome of Infants Younger Than 1 Year With Acute Lymphoblastic Leukemia Treated With the Interfant-06 Protocol: Results From an International Phase III Randomized Study.
J Clin Oncol. 2019 Sep 1;37(25):2246-2256. doi: 10.1200/JCO.19.00261. Epub 2019 Jul 8.
6
Intensified chemotherapy without SCT in infant ALL: results from COG P9407 (Cohort 3).
Pediatr Blood Cancer. 2015 Mar;62(3):419-26. doi: 10.1002/pbc.25322. Epub 2014 Nov 14.
7
Early use of allogeneic hematopoietic stem cell transplantation for infants with MLL gene-rearrangement-positive acute lymphoblastic leukemia.
Leukemia. 2015 Feb;29(2):290-6. doi: 10.1038/leu.2014.172. Epub 2014 Jun 3.
8
Analysis of the role of hematopoietic stem-cell transplantation in infants with acute lymphoblastic leukemia in first remission and MLL gene rearrangements: a report from the Children's Oncology Group.
J Clin Oncol. 2011 Jan 10;29(2):214-22. doi: 10.1200/JCO.2009.26.8938. Epub 2010 Dec 6.
9
Outcome of risk-based therapy for infant acute lymphoblastic leukemia with or without an MLL gene rearrangement, with emphasis on late effects: a final report of two consecutive studies, MLL96 and MLL98, of the Japan Infant Leukemia Study Group.
Leukemia. 2007 Nov;21(11):2258-63. doi: 10.1038/sj.leu.2404903. Epub 2007 Aug 9.
10
A treatment protocol for infants younger than 1 year with acute lymphoblastic leukaemia (Interfant-99): an observational study and a multicentre randomised trial.
Lancet. 2007 Jul 21;370(9583):240-250. doi: 10.1016/S0140-6736(07)61126-X.
Zotero 插件